Slideshow
Author(s):
Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.
From Neurology Enthusiast to Advocate for Health Equity: Moira Kapral’s SEQUINS Hall of Fame Journey
Special Episode: FDA Approves Tenecteplase for Acute Ischemic Stroke
Transforming Neurological Care Delivery: Barbara Vickrey’s SEQUINS Hall of Fame Journey
Episode 109: AB126, Exosomes, and Cerebroprotection for Stroke
Honoring 2025 SEQUINS Hall of Famers: Perspectives From Cheryl Bushnell, MD, MHS
FDA Clears INTRABEAM 700 as Supportive Device for Intraoperative Radiation Therapy